Russell Investments Group’s Larimar Therapeutics LRMR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $329 | Sell |
114
-79
| -41% | -$228 | ﹤0.01% | 3773 |
|
|
2025
Q1 | $415 | Buy |
+193
| New | +$415 | ﹤0.01% | 3690 |
|
|
2024
Q3 | – | Sell |
-1,755
| Closed | -$12.7K | – | 3748 |
|
|
2024
Q2 | $12.7K | Buy |
+1,755
| New | +$12.7K | ﹤0.01% | 3028 |
|
|
2021
Q2 | – | Sell |
-13,163
| Closed | -$192K | – | 3264 |
|
|
2021
Q1 | $192K | Hold |
13,163
| – | – | ﹤0.01% | 2844 |
|
|
2020
Q4 | $281K | Hold |
13,163
| – | – | ﹤0.01% | 2650 |
|
|
2020
Q3 | $199K | Hold |
13,163
| – | – | ﹤0.01% | 2778 |
|
|
2020
Q2 | $169K | Sell |
13,163
-8,607
| -40% | -$111K | ﹤0.01% | 2755 |
|
|
2020
Q1 | $201K | Sell |
21,770
-11,179
| -34% | -$103K | ﹤0.01% | 2554 |
|
|
2019
Q4 | $438K | Buy |
32,949
+15,489
| +89% | +$206K | ﹤0.01% | 2454 |
|
|
2019
Q3 | $155K | Buy |
+17,460
| New | +$155K | ﹤0.01% | 2693 |
|
|
2018
Q4 | – | Sell |
-42
| Closed | -$6K | – | 2991 |
|
|
2018
Q3 | $6K | Hold |
42
| – | – | ﹤0.01% | 2933 |
|
|
2018
Q2 | $5K | Buy |
+42
| New | +$5K | ﹤0.01% | 2889 |
|
|
2018
Q1 | – | Sell |
-1,762
| Closed | -$100K | – | 2955 |
|
|
2017
Q4 | $100K | Buy |
1,762
+234
| +15% | +$13.3K | ﹤0.01% | 2775 |
|
|
2017
Q3 | $65K | Buy |
1,528
+661
| +76% | +$28.1K | ﹤0.01% | 2826 |
|
|
2017
Q2 | $37K | Buy |
867
+576
| +198% | +$24.6K | ﹤0.01% | 2908 |
|
|
2017
Q1 | $16K | Sell |
291
-501
| -63% | -$27.5K | ﹤0.01% | 2958 |
|
|
2016
Q4 | $31K | Buy |
+792
| New | +$31K | ﹤0.01% | 3012 |
|